Soumerai, J. D., Ni, A., Xing, G., Huang, J., Furman, R. R., Jones, J., . . . Zelenetz, A. D. (2018). Evaluation of the CLL-IPI in Relapsed and Refractory Chronic Lymphocytic Leukemia in Idelalisib Phase 3 Trials. Leuk Lymphoma.
Citação norma ChicagoSoumerai, Jacob D., et al. "Evaluation of the CLL-IPI in Relapsed and Refractory Chronic Lymphocytic Leukemia in Idelalisib Phase 3 Trials." Leuk Lymphoma 2018.
Citação norma MLASoumerai, Jacob D., et al. "Evaluation of the CLL-IPI in Relapsed and Refractory Chronic Lymphocytic Leukemia in Idelalisib Phase 3 Trials." Leuk Lymphoma 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.